Simultaneous magnetic dispersive micro solid phase extraction of valsartan and atorvastatin using a CMC-coated Fe 3 O 4 nanocomposite prior to HPLC-UV detection: multivariate optimization
Authors:
- 8 October 2019
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 43 (43) , 16950-16959
Abstract
In the current study, a sensitive, rapid, accurate and practical procedure is established for determination of atorvastatin (AT) and valsartan (VAS) together from human biological fluids by dispersive micro solid phase extraction (D-μ-SPE) combined with a high-performance liquid chromatography-ultraviolet-visible detector (HPLC-UV). The Fe3O4@carboxymethyl cellulose (Fe3O4@CMC) nanocomposite was synthesized and employed as a magnetic adsorbent. The SEM, FT-IR, XRD, and VSM analytical techniques confirm the characteristics of the synthesized nanoadsorbent. The extraction process was optimized by central composite design (CCD) as the most popular response surface methodology (RSM). The optimum operational conditions are found in which pH = 7.0, 50 mg of the sorbent, sorption time 13 min, desorption time 5 min, sample volume 20 mL and a mixed solvent of 0.1 mL methanol, 0.2 mL acetonitrile, and 0.2 mL formic acid (3 : 100, v/v) as an efficient eluent solvent are used. Under the optimum experimental conditions, the linear dynamic ranges (LDRs), limits of detection (LODs), limits of quantitation (LOQs), enrichment factors (EFs) and relative standard deviations (RSDs) for VAS and AT were obtained to be as follows: EFs, 176 and 114; LODs, 2.4 and 2.1 μg L−1; LOQs 8.0 and 7.0 μg L−1, RSDs, 2.96 and 3.79 for AT and VAS, respectively; and LDRs, 10–2000 μg L−1. The proposed method described is successfully implemented to determine trace amounts of AT and VAS for human serum and urine matrices.Keywords
This publication has 52 references indexed in Scilit:
- Optimization of dispersive liquid–liquid microextraction with central composite design for preconcentration of chlordiazepoxide drug and its determination by HPLC‐UVJournal of Separation Science, 2013
- Microextraction by packed sorbent as sample preparation step for atorvastatin and its metabolites in biological samples—Critical evaluationJournal of Pharmaceutical and Biomedical Analysis, 2011
- Quantitation of atorvastatin in human plasma using directly suspended acceptor droplet in liquid–liquid–liquid microextraction and high-performance liquid chromatography-ultraviolet detectionTalanta, 2009
- HPLC determination of ibuprofen, diclofenac and salicylic acid using hollow fiber-based liquid phase microextraction (HF-LPME)Analytica Chimica Acta, 2009
- Determination of losartan, telmisartan, and valsartan by direct injection of human urine into a column-switching liquid chromatographic system with fluorescence detectionJournal of Pharmaceutical and Biomedical Analysis, 2009
- Valsartan vs. other angiotensin II receptor blockers in the treatment of hypertension: a meta-analytical approachInternational Journal Of Clinical Practice, 2009
- Simultaneous determination of fixed dose combination of nebivolol and valsartan in human plasma by liquid chromatographic-tandem mass spectrometry and its application to pharmacokinetic studyJournal of Chromatography B, 2007
- Development and validation of a method for quantitative determination of valsartan in human plasma by liquid chromatography-tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2007
- Optimizationvia experimental design of an SPE-HPLC-UV-fluorescence method for the determination of valsartan and its metabolite in human plasma samplesJournal of Separation Science, 2006
- Simultaneous determination of copper, nickel, cobalt and zinc using zincon as a metallochromic indicator with partial least squaresAnalytica Chimica Acta, 2003